Frédèric Selle
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment 80
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 15
- Oncology top 2%
- PARP inhibition in cancer therapy 25
- Cancer Treatment and Pharmacology 9
- Surgery top 5%
- Intraperitoneal and Appendiceal Malignancies 26
- Testicular diseases and treatments 9
-
- Renal cell carcinoma treatment 20
-
- BRCA gene mutations in cancer 9
Frédèric Selle
117 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 76
- Reproductive Medicine 1.1k
- Obstetrics and Gynecology 436
- Oncology 1.4k
- Surgery 940
- Pulmonary and Respiratory Medicine 599
Countries citing papers authored by Frédèric Selle
This map shows the geographic impact of Frédèric Selle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédèric Selle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédèric Selle more than expected).
Fields of papers citing papers by Frédèric Selle
This network shows the impact of papers produced by Frédèric Selle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédèric Selle. The network helps show where Frédèric Selle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frédèric Selle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 6 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 7 | |
| 9 | 2020 | 3 | |
| 10 | 2017 | 56 | |
| 11 | 2017 | 1 | |
| 12 | 2016 | 55 | |
| 13 | 2016 | 4 | |
| 14 | 2016 | 1 | |
| 15 | 2015 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2010 | 28 | |
| 18 | ABCB1 (MDR1) genotype in relation to doxorubicin and docetaxel pharmacokinetics in patients with breast cancer | 2007 | 1 |
| 19 | 2007 | 1 | |
| 20 | [Dose density and dose intensity in the treatment of breast cancer]. | 2004 | 4 |
About Frédèric Selle
Frédèric Selle is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 127 papers that have together received 2.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (80 papers), Intraperitoneal and Appendiceal Malignancies (26 papers), PARP inhibition in cancer therapy (25 papers), Renal cell carcinoma treatment (20 papers), Endometrial and Cervical Cancer Treatments (15 papers), BRCA gene mutations in cancer (9 papers), Testicular diseases and treatments (9 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Reproductive Medicine (1.1k citations), Obstetrics and Gynecology (436 citations), Oncology (1.4k citations), Surgery (940 citations) and Pulmonary and Respiratory Medicine (599 citations). Frédèric Selle has collaborated with scholars based in France, Italy and Spain. Frequent co-authors include Thierry André, Christophe Louvet, Roman Rouzier, Émile Daraï, E. Chéreau, Jean‐Pierre Lotz, Pascal Hammel, Aimery de Gramont, Philippe Ruszniewski and Jacques Balosso. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology and American Journal of Obstetrics and Gynecology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.